Acerus Pharmaceuticals Corporation

TSX:ASP 株式レポート

時価総額：CA$2.8m

This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

このページの翻訳は実験的なもので、現在開発中です。お待ちしております！

Acerus Pharmaceuticals マネジメント

マネジメント 基準チェック /24

主要情報

Ed Gudaitis

最高経営責任者

US$807.1k

報酬総額

CEO給与比率24.7%
CEO在任期間4.8yrs
CEOの所有権1.0%
経営陣の平均在職期間3.8yrs
取締役会の平均在任期間6yrs

経営陣の近況

Have Insiders Been Buying Acerus Pharmaceuticals Corporation (TSE:ASP) Shares?

Mar 12
Have Insiders Been Buying Acerus Pharmaceuticals Corporation (TSE:ASP) Shares?

The Independent Director of Acerus Pharmaceuticals Corporation (TSE:ASP), Stephen Gregory, Just Bought 52% More Shares

Nov 30
The Independent Director of Acerus Pharmaceuticals Corporation (TSE:ASP), Stephen Gregory, Just Bought 52% More Shares

Recent updates

Auditors Have Doubts About Acerus Pharmaceuticals (TSE:ASP)

Mar 14
Auditors Have Doubts About Acerus Pharmaceuticals (TSE:ASP)

Have Insiders Been Buying Acerus Pharmaceuticals Corporation (TSE:ASP) Shares?

Mar 12
Have Insiders Been Buying Acerus Pharmaceuticals Corporation (TSE:ASP) Shares?

Acerus Pharmaceuticals' (TSE:ASP) Shareholders Are Down 88% On Their Shares

Jan 22
Acerus Pharmaceuticals' (TSE:ASP) Shareholders Are Down 88% On Their Shares

The Independent Director of Acerus Pharmaceuticals Corporation (TSE:ASP), Stephen Gregory, Just Bought 52% More Shares

Nov 30
The Independent Director of Acerus Pharmaceuticals Corporation (TSE:ASP), Stephen Gregory, Just Bought 52% More Shares

CEO報酬分析

Acerus Pharmaceuticals の収益と比較して、Ed Gudaitis の報酬はどのように変化したか？
日付総報酬給与会社業績
Sep 30 2022n/an/a

-US$28m

Jun 30 2022n/an/a

-US$29m

Mar 31 2022n/an/a

-US$28m

Dec 31 2021US$807kUS$199k

-US$34m

Sep 30 2021n/an/a

-US$32m

Jun 30 2021n/an/a

-US$34m

Mar 31 2021n/an/a

-US$33m

Dec 31 2020US$664kUS$177k

-US$24m

Sep 30 2020n/an/a

-US$21m

Jun 30 2020n/an/a

-US$19m

Mar 31 2020n/an/a

-US$16m

Dec 31 2019US$190kUS$181k

-US$16m

Sep 30 2019n/an/a

-US$17m

Jun 30 2019n/an/a

-US$16m

Mar 31 2019n/an/a

-US$19m

Dec 31 2018US$394kUS$185k

-US$19m

報酬と市場: Ed's total compensation ($USD807.09K) is above average for companies of similar size in the Canadian market ($USD172.94K).

報酬と収益: Ed's compensation has increased whilst the company is unprofitable.

CEO（最高経営責任者

Ed Gudaitis

4.8yrs

在職期間

US$807,086

報酬

Mr. Edward Gudaitis, also known as Ed, is President, Director and Chief Executive Officer at Acerus Pharmaceuticals Corp. since May 01, 2018. He is a Director for BioteCanada. Mr. Gudaitis has spent many y...

リーダーシップ・チーム

名称ポジション在職期間報酬所有権
Edward Gudaitis
President4.8yrsUS$807.09k1.03%
$ 28.6k
Gavin Damstra
Senior Vice President of International Commercial3.8yrsUS$411.98kデータなし
Christopher Sorli
Chief Medical Officer2.7yrsUS$452.01kデータなし
Naveed Manzoor
Interim Chief Financial Officerless than a yearデータなしデータなし
Chris Witty
Investor Relationsno dataデータなしデータなし
Philippe Savard
Senior VP6.7yrsUS$287.97k0.0046%
$ 128.8
Hubert Czerwinski
President of Acerus Pharmaceuticals SRLno dataUS$306.94kデータなし

3.8yrs

平均在職期間

経験豊富な経営陣: ASP's management team is considered experienced (3.8 years average tenure).

取締役

名称ポジション在職期間報酬所有権
Edward Gudaitis
President4.8yrsUS$807.09k1.03%
$ 28.6k
Samuel Herschkowitz
Vice Chairmanless than a yearデータなし0.032%
$ 899.9
Ian Ihnatowycz
Chairman of the Board9.5yrsUS$46.15kデータなし
Stephen Gregory
Independent Director11.7yrsUS$38.12kデータなし
Borys Chabursky
Lead Independent Director7.3yrsUS$32.11k0.032%
$ 877.4
Geoffrey Cotton
Independent Director2.8yrsUS$44.01kデータなし

6.0yrs

平均在職期間

69yo

平均年齢

経験豊富なボード: ASP's board of directors are considered experienced (6 years average tenure).